Literature DB >> 24853317

Modified forward model for eliminating the time-varying impact in fluorescence molecular tomography.

Wei He1, Guanglei Zhang1, Huangsheng Pu1, Fei Liu1, Xu Cao2, Jianwen Luo3, Jing Bai1.   

Abstract

In conventional fluorescence molecular tomography, the distribution of fluorescent contrast agents is reconstructed with the assumption of constant concentration during data acquisition for each image frame. However, the concentration of fluorescent contrast target is usually time-varying in experiments or in-vivo studies. In this case, the reconstruction methods cannot be directly applied to the fluorescence measurements without considering the time-varying effects of concentration. We propose a modified forward model by dividing the fluorescence yield distribution into two parts: one is a constant representing the spatial distribution of the fluorescent target and the other is an impact factor representing the effects of the concentration change and other possible factors. By extracting spatial distribution information from the reconstruction result, the location and volume of the fluorescent target can be obtained accurately. Both simulation and phantom experiments are carried out and the results indicate that, by using the modified forward model, the quality of reconstruction could be significantly improved in terms of accurate localization and strong anti-noise ability.

Mesh:

Substances:

Year:  2014        PMID: 24853317     DOI: 10.1117/1.JBO.19.5.056012

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  2 in total

1.  Self-prior strategy for organ reconstruction in fluorescence molecular tomography.

Authors:  Yuan Zhou; Maomao Chen; Han Su; Jianwen Luo
Journal:  Biomed Opt Express       Date:  2017-09-25       Impact factor: 3.732

2.  Noninvasive Assessment of Elimination and Retention using CT-FMT and Kinetic Whole-body Modeling.

Authors:  Wa'el Al Rawashdeh; Simin Zuo; Andrea Melle; Lia Appold; Susanne Koletnik; Yoanna Tsvetkova; Nataliia Beztsinna; Andrij Pich; Twan Lammers; Fabian Kiessling; Felix Gremse
Journal:  Theranostics       Date:  2017-04-05       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.